Similarly, hypomethylation of TNF receptor-associated factor 3 (TRAF3), hypermethylation of thrombospondin-1 (THBS1), and increased DNA methyltransferase 3A (DNMT3A) activity are indicated as predictors of stroke outcome [41–43]. The gene discussed is TRAF3; the disease is Stroke.